Drug
cosibelimab
Marketed as UNLOXCYT.
Generic name
cosibelimab
Brand names
UNLOXCYT
First FDA approval
2024-12-13
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761297 | UNLOXCYT | 2024-12-13 | CHECKPOINT THERAPEUTICS INC |
Manufacturers
CHECKPOINT THERAPEUTICS INC
Frequently asked questions
When was cosibelimab FDA approved?
Earliest FDA approval on record: 2024-12-13.
What brand names are sold as cosibelimab?
UNLOXCYT.
Sources
Appeal a cosibelimab denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com